These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1792658)

  • 1. Prostanoids in therapy of peripheral arterial occlusive disease.
    Creutzig A; Caspary L
    Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of peripheral arterial occlusive disease with special reference to prostaglandins].
    Creutzig A
    Z Gesamte Inn Med; 1991 Mar; 46(3):59-67. PubMed ID: 1828125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
    D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
    Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
    Heidrich H
    Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease].
    Aligne C; Mosnier M; Mistretta F; Larguier JS
    J Mal Vasc; 2000 Jun; 25(3):187-94. PubMed ID: 10906634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases].
    Bucci M; Iacobitti P; Laurora G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):9-15. PubMed ID: 10658439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacotherapy and behavioral intervention for peripheral arterial disease.
    Doyle J; Creager MA
    Rev Cardiovasc Med; 2003; 4(1):18-24. PubMed ID: 12684600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current therapy of peripheral arterial occlusive diseases in the aged].
    Schütz RM
    Z Gerontol; 1992; 25(2):101-4. PubMed ID: 1609537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostanoid drug therapy for peripheral arterial occlusive disease--the European experience.
    Dormandy JA
    Vasc Med; 1996; 1(2):155-8. PubMed ID: 9546931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Operation and angioplasty in peripheral arterial occlusive disease].
    Heintzen MP; Strauer BE
    Z Kardiol; 1993; 82 Suppl 5():111-8. PubMed ID: 8154149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S; Claeys L
    Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
    Leschke M; Schoebel FC; Strauer BE
    Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostaglandin E1 in intermittent claudication].
    Scheffler P; de la Hamette D; Rogatti W
    Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
    Rudofsky G
    Wien Klin Wochenschr; 1988 Jul; 100(14):484-8. PubMed ID: 3062906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peripheral arterial occlusive disease of the lower extremities].
    Becker HM; Walter P
    Aktuelle Gerontol; 1983 Jul; 13(4):129-32. PubMed ID: 6137154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological treatment of chronic arterial occlusive disease (author's transl)].
    Dittrich J; Spaan G; Stein U; Wagner E; Frese JH
    Med Klin; 1979 Sep; 74(39):1396-403. PubMed ID: 492058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.